Organic growth for the spices and sauces maker is still expected to improve on 2024’s 1% pace at the top-end of the forecast ...

TD Cowen analysts adjusted their outlook on Union Pacific Corporation (NYSE: NYSE:UNP), increasing the price target from the ...

TD Cowen analysts maintained a positive outlook on Take-Two Interactive (NASDAQ:TTWO), currently trading at $182.89 with a ...

TD Cowen analyst Doug Creutz says Roblox (RBLX) saw a strong finish to the year following a “Dress to Impress” update in mid-December and ...

TD Cowen lowered the firm’s price target on Jack in the Box (JACK) to $42 from $50 and keeps a Hold rating on the shares. The firm said its ...

A U.S. watchdog is suing Capital One for allegedly misleading consumers about its offerings for high-interest savings ...

Hershey has announced the departure of CEO Michele Buck, who has been at the helm for more than seven years, effective 30 ...

Booz Allen Hamilton (NYSE:BAH – Get Free Report) had its price objective cut by stock analysts at TD Cowen from $200.00 to $155.00 in a report issued on Wednesday,Benzinga reports. The firm curr ...

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

Tuesday, analysts at TD Cowen began coverage on CG Oncology (NASDAQ:CGON) shares with a Buy rating, expressing confidence in the company's future prospects. The company, currently valued at $2.01 ...

TD Cowen initiated coverage of Centessa (CNTA) with a Buy rating and no price target The firm says the company’s ORX750 has a “best in class profile as a transformative therapy” in excessive ...

Maze Therapeutics intends to list its shares on the Nasdaq Global Market under the ticker symbol "MAZE". J.P. Morgan, TD Cowen, Leerink Partners and Guggenheim Securities are the lead underwriters of ...